X4 PHARMACEUTICALS, INC Shares Issued
X4 PHARMACEUTICALS, INC (XFOR) had Shares Issued of 96.11 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-06
- 2026-06-30: Common Stock, Shares, Issued 96.11M shares.
- 2026-03-31: Common Stock, Shares, Issued 94.32M shares.
- 2025-12-31: Common Stock, Shares, Issued 90.91M shares.
- 2025-09-30: Common Stock, Shares, Issued 25.15M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 96.11M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 94.32M shares 10-Q · filed 2026-05-06 | |
| 2025-12-31 | 90.91M shares 10-Q · filed 2026-08-06 | |
| 2025-09-30 | 25.15M shares 10-Q · filed 2025-11-05 | |
| 2025-06-30 | 7.96M shares 10-Q · filed 2025-08-08 | |
| 2025-03-31 | 5.79M shares 10-Q · filed 2025-05-01 | |
| 2024-12-31 | 5.70M shares 10-K · filed 2026-03-17 | 170.95M shares 10-K · filed 2025-03-26 |
| 2024-09-30 | 168.51M shares 10-Q · filed 2024-11-13 | |
| 2024-06-30 | 168.20M shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 167.94M shares 10-Q · filed 2024-05-07 | |
| 2023-12-31 | 167.43M shares 10-K · filed 2025-03-26 | |
| 2023-09-30 | 164.71M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 164.42M shares 10-Q · filed 2023-08-10 | |
| 2023-03-31 | 122.21M shares 10-Q · filed 2023-05-04 | |
| 2022-12-31 | 121.67M shares 10-K · filed 2024-03-21 | |
| 2022-09-30 | 68.73M shares 10-Q · filed 2022-11-03 | |
| 2022-06-30 | 30.99M shares 10-Q · filed 2022-08-04 | |
| 2022-03-31 | 30.81M shares 10-Q · filed 2022-05-12 | |
| 2021-12-31 | 28.13M shares 10-K · filed 2023-03-21 | |
| 2021-09-30 | 24.71M shares 10-Q · filed 2021-11-04 | |
| 2021-06-30 | 24.58M shares 10-Q · filed 2021-08-03 | |
| 2021-03-31 | 23.43M shares 10-Q · filed 2021-05-06 | |
| 2020-12-31 | 16.31M shares 10-K · filed 2022-03-17 | |
| 2020-09-30 | 16.29M shares 10-Q · filed 2020-11-05 | |
| 2020-06-30 | 16.18M shares 10-Q · filed 2020-08-04 | |
| 2020-03-31 | 16.14M shares 10-Q · filed 2020-05-07 | |
| 2019-12-31 | 16.13M shares 10-K · filed 2021-03-19 | |
| 2019-09-30 | 12.44M shares 10-Q · filed 2019-11-07 | |
| 2019-06-30 | 12.43M shares 10-Q · filed 2019-08-07 | |
| 2019-03-31 | 6.72M shares 10-Q · filed 2019-05-15 | |
| 2018-12-31 | 351.65K shares 10-K · filed 2020-03-12 | 14.57M shares 10-K · filed 2019-03-11 |
| 2018-09-30 | 14.32M shares 10-Q · filed 2018-11-09 | |
| 2018-06-30 | 14.32M shares 10-Q · filed 2018-08-13 | |
| 2018-03-31 | 14.29M shares 10-Q · filed 2018-05-10 | |
| 2017-12-31 | 14.29M shares 10-K · filed 2019-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |